ABASAGLAR

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug ABASAGLAR contains one active pharmaceutical ingredient (API):

1
UNII 2ZM8CX04RZ - INSULIN GLARGINE
 

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released.

 
Read more about Insulin glargine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10AE04 Insulin glargine A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1664906, 1664917, 1664928, 1664939, 1665031, 1665042, 1665053, 1665064, 1856134, 1856145
ES Centro de información online de medicamentos de la AEMPS 114944012
FI Lääkealan turvallisuus- ja kehittämiskeskus 138421, 448060, 451991
FR Base de données publique des médicaments 64332894, 66513085
GB Medicines & Healthcare Products Regulatory Agency 301720, 301724
IE Health Products Regulatory Authority 69486
LT Valstybinė vaistų kontrolės tarnyba 1074462, 1074466, 1074467, 1080467, 1080470, 1080471, 1091116, 1091117
NL Z-Index G-Standaard, PRK 121312
PL Rejestru Produktów Leczniczych 100332006
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65160002, W65161001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.